Ototoxicity of aminoglycoside drugs in tuberculosis treatment

South African Journal of Communication Disorders

 
 
Field Value
 
Title Ototoxicity of aminoglycoside drugs in tuberculosis treatment
 
Creator Voogt, G. R. Schoeman, H. S.
 
Subject — kanamycin; strepomycin; tuberculosis; high frequency hearing
Description The possible ototoxic effect of kanamycin, streptomycin and a standard anti-TB drug combination, used in the treatment of 92 TB patients (7-71 years old), was examined by measuring the highest audible electric bone conduction frequency before and after treatment, using an audimax 500 audiometer. At the so-called "safe" levels of drug administration it was found that kanamycin was markedly ototoxic effect. Furthermore, it was found that none of these drugs were gender specific. Lastly, the possible effects of ageing on highest audible bone conduction frequency is discussed.
 
Publisher AOSIS
 
Contributor
Date 1996-12-31
 
Type info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion — —
Format application/pdf
Identifier 10.4102/sajcd.v43i1.233
 
Source South African Journal of Communication Disorders; Vol 43, No 1 (1996); 3–6 2225-4765 0379-8046
 
Language eng
 
Relation
The following web links (URLs) may trigger a file download or direct you to an alternative webpage to gain access to a publication file format of the published article:

https://sajcd.org.za/index.php/sajcd/article/view/233/332
 
Coverage — — —
Rights Copyright (c) 2019 H. S. Schoeman https://creativecommons.org/licenses/by/4.0
ADVERTISEMENT